Fintel on MSN

Needham Reiterates InMode (INMD) Hold Recommendation

Fintel reports that on October 10, 2025, Needham reiterated coverage of InMode (NasdaqGS:INMD) with a Hold recommendation.

InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Gui…

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to ...
InvestorsHub on MSN

InMode Shares Gain After Preliminary Q3 Revenue Beats Expectations

Shares of InMode Ltd. (NASDAQ:INMD) climbed 9% on Thursday after the medical technology company released preliminary ...

InMode stock rises after preliminary Q3 revenue tops estimates

InMode also reaffirmed its full-year 2025 revenue guidance of $365 million to $375 million, which aligns with the current analyst consensus of $366.1 million. The company expects its non-GAAP gross ...
InvisionMag

AOA on Capitol Hill 2025: Nearly 600 Advocates Rally to Advance Optometry’s Priorities and Protect Patient Eye Health

This three-day fly-in highlights the AOA’s federal advocacy, linking frontline optometrists with Congress to advance key eye ...